Angiodynamic Inc (ANGO)

Insiders Buying Zumiez And 3 Other Stocks

Benzinga

AngioDynamics (ANGO) Q3 Earnings and Revenues Miss Estimates

Zacks Investment Research

AngioDynamics' (ANGO) AlphaVac Gets FDA Nod for PE Treatment

Zacks Investment Research

AngioDynamics (ANGO) Settles Patent Litigations With BD

Zacks Investment Research

Analysts Estimate AngioDynamics (ANGO) to Report a Decline in Earnings: What to Look Out for

Zacks Investment Research

AngioDynamics (ANGO) Declines More Than Market: Some Information for Investors

Zacks Investment Research

Why AngioDynamics (ANGO) Dipped More Than Broader Market Today

Zacks Investment Research

AngioDynamics (ANGO) Gains But Lags Market: What You Should Know

Zacks Investment Research

Here's Why AngioDynamics (ANGO) Gained But Lagged the Market Today

Zacks Investment Research

AngioDynamics (ANGO) Divests Its PICC & Midline Businesses

Zacks Investment Research

Why AngioDynamics (ANGO) Outpaced the Stock Market Today

Zacks Investment Research

AngioDynamics (ANGO) Stock Sinks As Market Gains: Here's Why

Zacks Investment Research

AngioDynamics' (ANGO) New XL Catheter to Help in PAD Treatment

Zacks Investment Research

Raymond James Maintains Outperform Rating for AngioDynamics: Here's What You Need To Know

Benzinga

AngioDynamics (ANGO) Q2 Earnings Top Estimates, Revenues Miss

Zacks Investment Research

Robinhood To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Monday

Benzinga

Why AngioDynamics Stock Got Destroyed Today

The Motley Fool

Why Applied Therapeutics Shares Are Trading Lower By Over 35%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Benzinga

AngioDynamics (ANGO) Reports Q2 Loss, Misses Revenue Estimates

Zacks Investment Research

US Stocks Poised To Extend New Year Slump As Focus Shifts To December Jobs Data: Analyst Sees S&P Testing 4,800 On This Condition

Benzinga

Investor Sentiment Edges Lower Ahead Of Jobs Report; Nasdaq Tumbles For 5th Consecutive Day

Benzinga

Costco Wholesale, Constellation Brands And 3 Stocks To Watch Heading Into Friday

Benzinga

Analysts Estimate AngioDynamics (ANGO) to Report a Decline in Earnings: What to Look Out for

Zacks Investment Research

Why AngioDynamics (ANGO) Outpaced the Stock Market Today

Zacks Investment Research

AngioDynamics (ANGO) Stock Drops Despite Market Gains: Important Facts to Note

Zacks Investment Research

AngioDynamics (ANGO) Falls More Steeply Than Broader Market: What Investors Need to Know

Zacks Investment Research

CVRx (CVRX) Moves 7.1% Higher: Will This Strength Last?

Zacks Investment Research

AngioDynamics (ANGO) Stock Slides as Market Rises: Facts to Know Before You Trade

Zacks Investment Research

AngioDynamics (ANGO) Outperforms Broader Market: What You Need to Know

Zacks Investment Research

AngioDynamics (ANGO) Stock Drops Despite Market Gains: Important Facts to Note

Zacks Investment Research